CAS: 2411440-41-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (S)-2-(5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carboxamido)-5-guanidinopentanoic acid REF: IN-DA0201XECAS: 2411440-41-8 | 95% | To inquire | Tue 21 Jan 25 |
 | JR14a REF: TM-T9316CAS: 2411440-41-8 | 99.29% | 90.00 €~1,003.00 € | Tue 28 Jan 25 |
 | JR14a REF: 3D-LWD44041CAS: 2411440-41-8 | Min. 95% | To inquire | Tue 04 Mar 25 |
(S)-2-(5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carboxamido)-5-guanidinopentanoic acid
CAS:2411440-41-8
Formula:
C25H26Cl2N4O3S
Purity:
95%
Molecular weight:
533.4699
Ref: IN-DA0201XE
| 5mg | 138.00 € | ||
| 10mg | 152.00 € | ||
| 25mg | 300.00 € | ||
| 50mg | 637.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
JR14a
CAS:2411440-41-8
JR14a (5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride) is a potent antagonist of human complement C3a receptor.
Formula:
C25H26Cl2N4O3S
Purity:
99.29%
Color and Shape:
Solid
Molecular weight:
533.47
Ref: TM-T9316
| 1mg | 90.00 € | ||
| 5mg | 184.00 € | ||
| 10mg | 292.00 € | ||
| 25mg | 495.00 € | ||
| 50mg | 714.00 € | ||
| 100mg | 1,003.00 € | ||
| 1mL*10mM (DMSO) | 214.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
JR14a
CAS:2411440-41-8
JR14a is an analog inhibitor of protein kinases, which has shown promising results in the …
Formula:
C25H26Cl2N4O3S
Purity:
Min. 95%
Molecular weight:
533.5 g/mol
Ref: 3D-LWD44041
| 25mg | 1,006.00 € | ||
| 50mg | 1,400.00 € | ||
| 100mg | 2,239.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
